- Home
- BGLC vs FTFT Comparison
BGLC vs FTFT Comparison
Compare BGLC & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- FTFT
- Stock Information
- Founded
- BGLC 2017
- FTFT N/A
- Country
- BGLC Malaysia
- FTFT United States
- Employees
- BGLC N/A
- FTFT N/A
- Industry
- BGLC Medical Specialities
- FTFT Business Services
- Sector
- BGLC Health Care
- FTFT Consumer Discretionary
- Exchange
- BGLC Nasdaq
- FTFT Nasdaq
- Market Cap
- BGLC 10.7M
- FTFT 5.4M
- IPO Year
- BGLC N/A
- FTFT N/A
- Fundamental
- Price
- BGLC $3.89
- FTFT $2.55
- Analyst Decision
- BGLC
- FTFT
- Analyst Count
- BGLC 0
- FTFT 0
- Target Price
- BGLC N/A
- FTFT N/A
- AVG Volume (30 Days)
- BGLC 2.7M
- FTFT 5.0M
- Earning Date
- BGLC 08-13-2025
- FTFT 08-18-2025
- Dividend Yield
- BGLC N/A
- FTFT N/A
- EPS Growth
- BGLC N/A
- FTFT N/A
- EPS
- BGLC N/A
- FTFT N/A
- Revenue
- BGLC $9,265,870.00
- FTFT $2,031,913.00
- Revenue This Year
- BGLC N/A
- FTFT N/A
- Revenue Next Year
- BGLC N/A
- FTFT N/A
- P/E Ratio
- BGLC N/A
- FTFT N/A
- Revenue Growth
- BGLC N/A
- FTFT N/A
- 52 Week Low
- BGLC $2.01
- FTFT $1.01
- 52 Week High
- BGLC $15.60
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- BGLC 52.61
- FTFT 64.90
- Support Level
- BGLC $5.33
- FTFT $1.16
- Resistance Level
- BGLC $6.39
- FTFT $1.16
- Average True Range (ATR)
- BGLC 1.18
- FTFT 0.12
- MACD
- BGLC 0.10
- FTFT 0.05
- Stochastic Oscillator
- BGLC 19.15
- FTFT 87.72
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.